BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12624612)

  • 1. Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
    Fogari R; Malamani GD; Zoppi A; Mugellini A; Rinaldi A; Vanasia A; Preti P
    J Hum Hypertens; 2003 Mar; 17(3):207-12. PubMed ID: 12624612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
    Fogari R; Zoppi A; Derosa G; Mugellini A; Lazzari P; Rinaldi A; Fogari E; Preti P
    J Hum Hypertens; 2007 Mar; 21(3):220-4. PubMed ID: 17215848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients.
    Fogari R; Malamani G; Corradi L; Mugellini A; Preti P; Zoppi A; Derosa G
    Adv Ther; 2010 Jan; 27(1):48-55. PubMed ID: 20174905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension.
    Ueng KC; Lin LC; Voon WC; Lin MC; Liu YB; Su HM; Chang PY; Lin TH; Chen WL; Wu CC; Lai WT; Lin CS
    Blood Press Suppl; 2008 Jun; 1():24-31. PubMed ID: 18705532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG; Bakris GL
    Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study.
    Fogari R; Zoppi A; Mugellini A; Maffioli P; Lazzari P; Monti C; Derosa G
    Expert Opin Pharmacother; 2011 Jun; 12(9):1351-8. PubMed ID: 21510830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
    Fogari R; Preti P; Lazzari P; Corradi L; Zoppi A; Fogari E; Mugellini A
    Eur J Clin Pharmacol; 2003 Aug; 59(4):271-5. PubMed ID: 12830340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study.
    Fogari R; Malamani G; Zoppi A; Mugellini A; Rinaldi A; Fogari E; Perrone T
    Clin Ther; 2007 Mar; 29(3):413-8. PubMed ID: 17577462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension.
    Malacco E; Piazza S; Carretta R; Di Somma S; Mugellini A; Bertocchi F; Palatini P;
    Int J Clin Pharmacol Ther; 2002 Jun; 40(6):263-9. PubMed ID: 12078940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients.
    Fogari R; Zoppi A; Maffioli P; Lazzari P; Mugellini A; Derosa G
    Expert Opin Pharmacother; 2011 Nov; 12(16):2441-8. PubMed ID: 21958068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
    Bakris G; Hester A; Weber M; Dahlof B; Pitt B; Velasquez E; Staikos-Byrne L; Shi V; Jamerson K;
    J Cardiometab Syndr; 2008; 3(4):229-33. PubMed ID: 19040592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.